<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

43

No.

24

June 16, 2017Jun 16, 2017

DOWNLOAD THE PDF

Ned Sharpless, Trump's choice for NCI director, described as erudite scientist whose expertise spans basic, clinical research

Cover Story

Ned Sharpless, Trump's choice for NCI director, described as erudite scientist whose expertise spans basic, clinical research

By Paul Goldberg

President Donald Trump announced his intention to name Norman “Ned” Sharpless to serve as the next NCI director. The appointment was announced late on June 9.

Sandoz prevails over Amgen in Supreme Court case on marketing biosimilars

Sandoz prevails over Amgen in Supreme Court case on marketing biosimilars

By Claire Dietz

NIH plans to set aside up to $1.1 billion a year to fund more young investigators

NIH plans to set aside up to $1.1 billion a year to fund more young investigators

By Matthew Bin Han Ong

Recent Issues

Volume 50 | Issue 43 - November 15, 2024

Volume 50 | Issue 42 - November 08, 2024

Volume 50 | Issue 41 - November 01, 2024

Volume 50 | Issue 40 - October 25, 2024

Volume 50 | Issue 39 - October 18, 2024

Volume 50 | Issue 38 - October 11, 2024